Paying user area
Try for free
Allergan Inc. pages available for free this week:
- Income Statement
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Liquidity Ratios
- Analysis of Geographic Areas
- Price to FCFE (P/FCFE)
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Allergan Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Inventory Disclosure
Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Finished products | |||||||||||
Work in process | |||||||||||
Raw materials | |||||||||||
Inventories |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
- Finished Products
- Finished products exhibited a generally upward trend over the five-year period, increasing from $148.2 million in 2010 to $188.3 million in 2014. Although there was a slight decline between 2012 and 2013, the overall trajectory suggests growth in this inventory category.
- Work in Process
- Work in process inventory showed a gradual increase from $41.1 million in 2010 to $50.5 million in 2014. The values rose steadily each year except for a minor dip between 2010 and 2011, indicating ongoing investment or accumulation in production phases.
- Raw Materials
- Raw materials inventory displayed fluctuations, growing from $40.1 million in 2010 to a peak of $61.2 million in 2013 before declining somewhat to $57.2 million in 2014. This suggests some volatility in procurement or usage patterns of raw materials.
- Inventories (Total)
- Total inventories increased consistently from $229.4 million in 2010 to $296.0 million in 2014. This steady rise highlights an expansion in overall inventory holdings, which may reflect business growth or changes in inventory management strategy.